Vue transversale de la maladie
Migraine
Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.
Périmètre
Filtrer toute la vue
Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.
1236 résultats correspondants
· 45 visibles sur cette page
dans le périmètre Migraine
Niveau clinique
Études et traitements 570
Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| I-SPY-RCT — Intervention for Sleep and Pain in Youth: A Randomized Co… NCT04936321 · NCT04936321 | Migraine | Ralentissement de la progression · Traitement symptomatique | Non applicable | COMPLETED | Insomnia is a common comorbidity among adolescents with migraine. This ran… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:04 | Détail |
| Prasugrel 5mg NCT07629635 · COMFORT-PFO — Migraine Headaches Elimination With Patent Foramen Ovale-Directed… | Migraine | À vérifier | Phase 3 | NOT_YET_RECRUITING | Migraine is a common and often disabling condition, but its exact causes a… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:04 | Détail |
| Rimegepant NCT06616194 · A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With… | Migraine | À vérifier | Phase 3 | ACTIVE_NOT_RECRUITING | The purpose of this study is to evaluate safety and tolerability of BHV-30… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:04 | Détail |
| Rimegepant NCT05156398 · Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migrai… | Migraine | À vérifier | Phase 3 | RECRUITING | The purpose of this study is to evaluate safety and tolerability of BHV-30… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:04 | Détail |
| Yogabased Movements for Primary Headaches (Migraine and/or Cluster He… NCT07348783 · NCT07348783 | Migraine | Traitement symptomatique · Thérapie génique | Non applicable | RECRUITING | Brief Summary: Migraine and/or Cluster Headache: Study Overview \*\*Backgr… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:04 | Détail |
| Yogabased Movements for Primary Headaches (Migraine and/or Cluster He… NCT07292090 · NCT07292090 | Migraine | Traitement symptomatique · Thérapie génique | Non applicable | ACTIVE_NOT_RECRUITING | Migraine and/or Cluster Headache: Study Overview \*\*Background:\*\* Migra… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:04 | Détail |
| Amitriptyline NCT05889624 · Responding With Evidence and Access for Childhood Headaches | Migraine | À vérifier | Non applicable | RECRUITING | This comparative effectiveness study will clarify current first-line preve… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:03 | Détail |
| A Study of Wearable Devices to Predict Migraines NCT05755945 · NCT05755945 | Migraine | À vérifier | Non applicable | ACTIVE_NOT_RECRUITING | The purpose of this research is to determine if data from smart devices, i… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:03 | Détail |
| Botulinum toxin type A NCT04069897 · MiBlock — Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Trea… | Migraine | Traitement symptomatique | Phase 3 | COMPLETED | The main purpose of this study is to determine which is the best dose of a… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:03 | Détail |
| CAVA Device NCT04026516 · CAVA: Dizziness Trial | Migraine | À vérifier | Non applicable | COMPLETED | Clinical investigation of a medical device (CAVA) for recording eye moveme… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:03 | Détail |
| Elismetrep NCT07645924 · A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute T… | Migraine | À vérifier | Phase 3 | RECRUITING | This is a long-term safety study to evaluate the safety and tolerability o… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:03 | Détail |
| EVO756, Dose 1 NCT07616128 · Study of EVO756 in Adults With Migraine | Migraine | À vérifier | Phase 2 | RECRUITING | This study will evaluate the efficacy and safety of EVO756 against placebo… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:03 | Détail |
| Galcanezumab NCT06085144 · Emgality for Migraine in Breastmilk | Migraine | À vérifier | À vérifier | RECRUITING | The main purpose of this study is to evaluate the efficacy of the study dr… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:03 | Détail |
| Headache Ear Auditory Dizziness Sinus (HEADS) Registry NCT07754266 · NCT07754266 | Migraine | Traitement symptomatique | À vérifier | RECRUITING | The Headache, Ear, Auditory, Dizziness, Sinus (HEADS) Registry is a study… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:03 | Détail |
| HEADS-UP — Headache Education and Awareness vs. Daily Mindfulness Str… NCT07513662 · NCT07513662 | Migraine | Traitement symptomatique · Thérapie génique | Non applicable | NOT_YET_RECRUITING | The goal of this study (supported by and included in the NIH HEAL Initiati… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:03 | Détail |
| Melatonin NCT07743255 · Preventive Role of Melatonin and Propranolol Administration in Pediatric Migraine | Migraine | Ralentissement de la progression · Traitement symptomatique · Thérapie génique | Non applicable | ENROLLING_BY_INVITATION | This randomized controlled trial evaluated whether adding melatonin to pro… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:03 | Détail |
| PRIMUS NCT06450444 · The RECLAIM Study. | Migraine | À vérifier | Non applicable | RECRUITING | The purpose of this study is to evaluate the safety and performance, inclu… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:03 | Détail |
| Rimegepant NCT07751497 · VERIFY — A Randomized, Open-Label, Multi-Center Study of Vestibular Migraine Pre… | Migraine | À vérifier | Phase 2 | NOT_YET_RECRUITING | The purpose of this study is to evaluate safety and tolerability of BHV-30… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:03 | Détail |
| Rimegepant (PF-07899801) NCT04743141 · Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatme… | Migraine | À vérifier | Phase 3 | RECRUITING | The purpose of this study is to test the long-term safety of rimegepant in… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:03 | Détail |
| Transcranial Direct Current stimulation NCT07743814 · EFFECT OF ANODAL TRANSCRANIAL DIRECT CURRENT STIMULATION (tDCS) OF PRIMARY MOTOR… | Migraine | Traitement symptomatique | Phase 3 | NOT_YET_RECRUITING | Migraine is a common, heterogeneous neurological disorder affecting approx… À vérifier | ClinicalTrials.gov 2026-08-13 14:17:03 | Détail |
Découverte scientifique
Recherches et trouvailles 0
Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Aucune trouvaille ne correspond aux filtres. | |||||||
Bibliographie
Publications 661
Références bibliographiques de la base locale et accès à leur source originale.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Active machine learning model for the dynamic simulation and growth m… TI-001 · PMID 38184678 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Substrate-catalyzed growth offers a highly promising approach for the controlled synthesis of carbon nanostructures. Ho… | Nature communications 2026-08-08 00:59:56 | Source |
| Combined Occipital Nerve and Sphenopalatine Ganglion Neuromodulation… Occipital Nerve Stimulation · PMID 42100751 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Craniofacial complex regional pain syndrome (CRPS) is a rare, diagnostically challenging condition characterized by sym… | Local and regional anesthesia 2026-08-08 00:59:56 | Source |
| Comparative Efficacy and Acceptability of Noninvasive Brain Stimulati… Occipital Nerve Stimulation · PMID 42473074 | Migraine | À vérifier | Publication | PubMed | Voir la publication source This network meta-analysis (NMA) aimed to compare and rank the efficacy and acceptability of different noninvasive brai… | Brain and behavior 2026-08-08 00:59:56 | Source |
| TiO2 nanotubes: interdependence of substrate grain orientation and gr… TI-001 · PMID 25545715 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Highly ordered arrays of TiO2 nanotubes can be produced by self-organized anodic growth. It is desirable to identify ke… | ACS applied materials & interfaces 2026-08-08 00:59:56 | Source |
| International Headache society evidence-based guidelines on the use o… Nerivio Migra-1 Sham device · PMID 41117312 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source ObjectiveTo develop evidence-based clinical practice guidelines for non-invasive neuromodulation devices in acute and p… | Cephalalgia : an international journal of headache 2026-08-08 00:59:54 | Source |
| Plasma Phosphorylated Tau 217 in Participants at Risk for Chronic Tra… BE WELL With Migraine: Brain Education and WELLness With Migraine · PMID 42440317 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source In vivo biomarkers for detecting neuropathologies from repetitive head impacts (RHI), including chronic traumatic encep… | JAMA network open 2026-08-08 00:59:53 | Source |
| Weight loss with atogepant in the long-term treatment of migraine: An… BE WELL With Migraine: Brain Education and WELLness With Migraine · PMID 42396885 | Migraine | À vérifier | Publication | PubMed | Voir la publication source To assess weight loss with atogepant 60 mg once daily during long-term treatment of chronic migraine (CM) and episodic… | Headache 2026-08-08 00:59:53 | Source |
| Cellulose and Its Derivatives in Drug Delivery: Recent Advances and A… sumatriptan succinate · PMID 42198288 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Drug delivery systems have long faced a fundamental challenge: achieving high drug-loading efficiency, precise control… | Pharmaceutics 2026-08-08 00:59:51 | Source |
| Spatial metabolomics combined with MALDI-MSI unveils gut-brain axis m… sumatriptan succinate · PMID 41619552 | Migraine | Immunomodulation · Traitement symptomatique · Thérapie génique | Publication | PubMed | Voir la publication source Migraine is a highly disabling neurological disorder characterized by recurrent headaches and complex metabolic disturb… | Phytomedicine : international journal of phytotherapy… 2026-08-08 00:59:51 | Source |
| Drugs targeting nitric oxide synthase for migraine treatment. NXN-188 · PMID 24818644 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Ample evidence that nitric oxide (NO) is a causative molecule in migraine has encouraged research to develop drugs that… | Expert opinion on investigational drugs 2026-08-08 00:59:50 | Source |
| The nitric oxide synthase inhibitor and serotonin-receptor agonist NX… NXN-188 · PMID 29913885 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Background and aims NXN-188 is a combined neuronal nitric oxide synthase (nNOS) inhibitor and 5HT-1B/1D receptor agonis… | Scandinavian journal of pain 2026-08-08 00:59:50 | Source |
| Identifying central positional vertigo to prevent diagnostic pitfalls… Vestibular System in Migrainous Vertigo Patients · PMID 42564662 | Migraine | À vérifier | Publication | PubMed | Voir la publication source This case series highlights the critical role of radiological imaging in patients presenting with positional vertigo in… | Radiology case reports 2026-08-08 00:59:48 | Source |
| Quantitative pupillometry as a marker of autonomic dysregulation in v… Vestibular System in Migrainous Vertigo Patients · PMID 42548108 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source Vestibular migraine (VM) has been associated with altered central sensory processing; however, objective measures of au… | Journal of oral & facial pain and headache 2026-08-08 00:59:48 | Source |
| Arterial hepatic perfusion is preserved during early resuscitation af… blood withdrawal · PMID 42431156 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Hemorrhagic shock is a major contributor to morbidity and mortality after polytrauma and plays a central role in the de… | Injury 2026-08-08 00:59:47 | Source |
| Long peripheral catheters for short-term vascular access: A 7-day obs… blood withdrawal · PMID 42438309 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source Long peripheral catheters are increasingly used as an alternative to short peripheral catheters for short-term intraven… | The journal of vascular access 2026-08-08 00:59:47 | Source |
| A Real-World Evidence Study on US Patients Demonstrating Safety of Hi… Nerivio ® · PMID 41886224 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Remote electrical neuromodulation (REN) is an FDA-cleared, nonsignificant-risk, drug-free, prescribed wearable device (… | Pain and therapy 2026-08-08 00:59:45 | Source |
| Association of adverse childhood experiences with physical illness an… Brief Interventions in Chronic Migraine · PMID 40194777 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Adverse childhood experiences (ACEs) are highly prevalent and associated with life-long health consequences. Here, we i… | European journal of public health 2026-08-08 00:59:45 | Source |
| Non-Pharmacological Treatment of Primary Headaches-A Focused Review. Brief Interventions in Chronic Migraine · PMID 37891800 | Migraine | Traitement symptomatique · Thérapie génique | Publication | PubMed | Voir la publication source Headache disorders are a significant global health burden, leading to reduced quality of life. While vast pharmacologic… | Brain sciences 2026-08-08 00:59:45 | Source |
| U.S. Veterans Using Remote Electrical Neuromodulation for Migraine: A… Nerivio ® · PMID 42520312 | Migraine | Ralentissement de la progression · Traitement symptomatique | Publication | PubMed | Voir la publication source Among U.S. veterans, migraine and other headache disorders are common, and frequently co-occur with other comorbidities… | Military medicine 2026-08-08 00:59:45 | Source |
| 2025 guideline update to acute treatment of migraine for adults in th… Greater Occipital Nerve Block with dexamethasone and lidocaine · PMID 41321235 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source To update the 2016 American Headache Society (AHS) guideline on parenteral pharmacologic therapies for the management o… | Headache 2026-08-08 00:59:43 | Source |
Exploration — prudence
Pistes exploratoires 5
Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.
Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Bavisant BRAVEinMS — Bavisant | Migraine | Remyélinisation · Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Antagonisme du récepteur H3 de l’histamine Bavisant est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pour Migra… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| Tol-MP Tol-MP — tolérance immunitaire spécifique de la myéline | Migraine | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Microparticules biodégradables chargées en rapamycine et fonctionnalisées… Tol-MP est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pour Migrain… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| SetPoint System SetPoint System — SetPoint Medical | Migraine | Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | re ApplicationsPublicationsCompanyCareersNewsGet startedGet startedNewsThe… SetPoint System est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pou… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| 4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation | Migraine | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation immunométabolique de la microglie 4-octyl itaconate et dérivés est étudié dans Sclérose latérale amyotrophique et documente plusieurs axes biologiques po… | Rapprochement Biomedical Watch · Sclérose latérale amy… | Détail |
| N-PPG N-PPG — modulation métabolique cérébrale | Migraine | Remyélinisation indirecte / réparation · Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation métabolique et mitohormèse N-PPG est étudié dans Maladie de Huntington et documente plusieurs axes biologiques pouvant être pertinents pour Migrai… | Rapprochement Biomedical Watch · Maladie de Huntington | Détail |